Non-Pharmacologic Approaches in Managing Hypertension Among The Elderly of Barangay Bagong Silang
Non-Pharmacologic Approaches in Managing Hypertension Among The Elderly of Barangay Bagong Silang
ISSN No:-2456-2165
Abstract:- Conclusion
The study concludes that non-pharmacologic
Background and Aim approaches to managing hypertension are underutilized,
This study aims to examine the use and reflecting a need for greater awareness and promotion of
effectiveness of non-pharmacologic approaches to these methods. Integrating lifestyle changes with
manage hypertension by focusing on lifestyle medication could improve hypertension management,
modifications including dietary modifications, physical but requires more education and support from
activity, and alternative therapies used by people with healthcare providers.
hypertension. The justification for this study is based on
the increasing awareness and understanding that while I. INTRODUCTION
medications are important in controlling blood pressure,
non-drug treatments can help to improve treatment The most common disease in the world is
outcomes. However, there is limited knowledge about the hypertension. There are many kinds of hypertension, and it
existence and use of these non-pharmacologic shows complications if it is not treated as early as the
approaches that this study seeks to generate by symptos shows. A study shows that primary, essential, and
examining their prevalence in influencing hypertension idiopathic hypertension is defined as high blood pressure
management. that is not associated with identifiable causes such as
endovascular disease, renal failure, pheochromocytoma, and
Methods aldosteronism (Elkheshebi et al. 2021). The same study also
The study used a quantitative, descriptive emphasizes the need for patients to treat high blood in its
approach, collecting data via questionnaires from adults initial stages as it may lead to difficult complications such as
with hypertension. The questionnaires assessed the heart disease, and vascular disease, in which, even lack of
frequency and types of non-pharmacologic treatments attention to treatment, may lead to kidney failure.
used. Descriptive statistics, including means and
standard deviations, were employed to analyze the data, Many factors affect hypertension. It is a challenge to
focusing on the prevalence and patterns of these non- reduce blood pressure solely through interventions. Diet
drug approaches in managing hypertension. intake plays a huge part in the healthy lifestyle of patients
experiencing cardiovascular disease (Elkheshebi et al.
Results 2021). It shows that 46.3% of patients were committed to
The study supports the merit of non- consuming healthy foods which, according to the data
pharmacological measures in hypertension management gathered, decreased to 17 patients experiencing controlled
through dietary modification, regular exercise, and blood pressure.
stress reduction. The strategies have dual advantages in
promoting general health, impacting several lifestyle Thus, the preference for a healthy life and avoiding
factors, and, at the same time, reducing risks associated physical activity negatively affects the patient's condition. It
with medications. This approach teaches long-lasting may influence the control of the patient's blood pressure,
healthy habits and decreases the cost of care, increasing which puts them at risk of raising it over the recommended
the chance of more significant patient engagement and level. The necessity of increasing awareness of non-
better adherence to outcomes. Non-pharmacological pharmacological interventions as a Complementary method
means may prevent hypertension in subjects at risk and to drug therapy among patients is emphasized. It would be
complement drug therapy by enhancing compliance with helpful for general practitioners to ensure patients are
medication and reducing the doses of drugs required. sticking to their non-pharmacological treatment plans and to
These methods are easily individualized according to check in with them regularly. There are differences in the
individual preference and therefore more effective and evidence regarding hypertension incidences, risk factors,
sustainable. and treatment strategies. The effectiveness of standard
treatment, also known as pharmacological treatment, for
patients with hypertension, does not include strategies like methods (Wright 2017). The use of a quantitative research
lifestyle modifications such as dietary changes, physical approach is driven by the need to explore the perspective of
activity, or educational initiatives. These are the non- non-pharmacological management and intervention of
pharmacological treatment approaches (Cernota et al. 2022). hypertension.
Table 1 Level of Prevalence of Utilization of the Listed Non-Pharmacological Treatments among Individuals Managing
Hypertension
Indicators Mean SD Interpretation
Dietary Changes (Reducing Salt Intake, DASH Diet, Potassium 3.45 1.03 Always
Increase)
Regular And Physical Activity (walking, hiking, jogging, etc.) 3.48 0.97 Always
B. Average Blood Pressure However, the data also highlighted the presence of
In Table 2, the distribution of respondents' average hypertension stages among the respondents. Notably, 6% of
blood pressure levels was presented, providing insightful the sample recorded a blood pressure of 120/100, and 3%
data on the cardiovascular health of the population studied. had readings of 130/100, indicating Stage 1 hypertension.
Overall, the data showed a wide range of blood pressure
readings among the respondents, with a significant portion Furthermore, isolated instances of more severe
falling within what was considered the normal range. hypertension, such as 150/90 and 190/90, though less
Specifically, the most common blood pressure level common (each at 1%), were of particular concern and
recorded was 120/80, observed in 37 respondents, suggested the need for targeted interventions to address high
accounting for 37% of the total sample. This indicated a blood pressure within this subgroup.
predominant tendency towards a healthy cardiovascular
state within the group.
C. Prevalence of the Integrated Use of Pharmacologic and Non-Pharmacologic Approaches in Managing Hypertension
Table 3 presented the level of prevalence of the integrated use of pharmacologic and non-pharmacologic approaches in
managing hypertension among respondents. The overall mean level of prevalence for these combined approaches was 3.20 (SD =
2.29), indicating that, on average, these practices were rarely utilized by patients. This low average usage suggested that many
patients might have been unaware of the benefits of combining different treatments for hypertension. It also highlighted a
potential area for healthcare providers to educate patients about how using both medication and lifestyle changes could effectively
manage their condition.
This low average usage suggested that many patients might have been unaware of the benefits of combining different
treatments for hypertension. It also highlighted a potential area for healthcare providers to educate patients about how using both
medication and lifestyle changes could effectively manage their condition. By understanding and addressing the reasons behind
the rare utilization of combined approaches, healthcare systems could improve hypertension management and patient outcomes.
In the category where the integrated use of pharmacologic and non- pharmacologic methods was “sometimes practiced”, the
mean scores ranged from 3.51 to 4.23, with standard deviations between 2.34 and 2.48. Notable combinations this group included
Losartan with dietary changes (M = 4.23, SD = 2.34) and Losartan with regular physical activity (M = 4.04, SD = 2.35). These
combinations suggested that patients were somewhat more likely to incorporate lifestyle modifications such as diet and exercise
when managing hypertension alongside medication.
Conversely, some integrated approaches were “infrequently practiced”, with mean scores ranging from 1.97 to 2.15 and
standard deviations between 1.74 and 1.89. Examples included Losartan with olive leaf extract (M = 1.97, SD = 1.74) and losartan
with fish oil (M = 2.15, SD = 1.89). These findings indicated a lower prevalence of using certain alternative or supplementary
therapies with conventional pharmacologic treatments. This low prevalence might have been due to a lack of awareness or
skepticism about the effectiveness of these alternative therapies among patients and healthcare providers.
Table 3 Level of Prevalence of the Integrated Use of Pharmacologic and Non- Pharmacologic Approaches in Managing
Hypertension
Indicators Mean SD Interpretation
Amlodipine+ Regular Physical Activity 3.51 2.48 Sometimes
Losartan + Dietary Changes 4.23 2.34 Sometimes
Losartan + Regular Physical Activity 4.04 2.35 Sometimes
Dietary Pattern of the Patient (Consume the Following Foods in Their Diet)
Table 4 provides an overview of respondents' consumption habits across various food categories. Red meat, including beef,
pork, and lamb, was predominantly consumed weekly by 44% of respondents, indicating its significance as a staple protein source
influenced by availability and cultural preferences. Poultry, such as chicken and turkey, saw daily consumption by 10% of
respondents, suggesting a preference for leaner protein options and potential health benefits. Fish and seafood were consumed
daily by 51% of respondents, pointing towards a strong cultural or dietary inclination towards these sources’ rich in omega-3 fatty
acids and lean protein. Eggs and dairy products were consumed daily by 47% of respondents, highlighting their importance for
nutritional needs due to affordability, versatility, and nutritional value.
Conversely, fruits were consumed daily by 67% of respondents, emphasizing their role in meeting daily nutritional
requirements and promoting overall health. Vegetables were consumed daily by 73% of respondents, indicating a strong emphasis
on vegetable intake for essential nutrients and fiber. Legumes, such as beans and lentils, were consumed daily by 38% of
respondents, showcasing their significance in providing daily protein and fiber intake in plant-based diets. Grains and cereals,
including rice, bread, and pasta, were consumed daily by 51% of respondents, serving as dietary staples rich in carbohydrates and
fiber. Snack foods, like chips and candies, were consumed weekly by 30% of respondents.
Table 4 Distribution of the Respondents on How Often Do They Consume the Following Foods in Their Diet
Indicators Daily Weekly Monthly Yearly Never Total
Red meat (beef, pork, lamb) (f) 4 44 49 3 0 100
(%) 4.0% 44.0% 49.0% 3.0% - 100.0%
Dietary Pattern of the Patient (Often that Drink the Following Beverages)
Table 5 provided an overview of respondents' beverage consumption habits, revealing distinct trends in consumption
frequencies. Water stood out 96% reporting daily intake, showcasing a widespread commitment to hydration for overall health.
Alcoholic drinks were consumed yearly by 38%, indicating a more occasional indulgence, possibly reflecting a balanced approach
to alcohol consumption and awareness of associated health risks.
However, fruit juices were a weekly staple for 63% of respondents, suggesting a preference for vitamin-rich options. Soft
drinks or sodas were consumed weekly by Coffee emerged as a daily ritual.
Table 5 Frequency and Distribution of the Respondents on How Often Do They Drink the following beverages
Indicators Daily Weekly Monthly Yearly Never Total
Water (f) 96 4 0 0 0 100
Losartan with regular physical activity, showed higher usage It was also recommended that future studies use
rates, indicating that patients might have been more objective measures, such as clinical evaluations and
receptive to lifestyle modifications when recommended biomarker assessments, alongside self-reported data to
alongside medication. Encouraging patients to adopt these improve the reliability and validity of the results. Lastly,
integrated Approaches could have led to better hypertension increasing awareness and education on lesser-known non-
management and potentially reduced reliance on medication pharmacological treatments through healthcare provider
alone, ultimately improving patient outcomes and quality of training and patient education programs could have been a
life. vital area for intervention and study.
In previous years, the key considerations of the non- Therefore, when looking for other forms of
pharmacologic therapies for hypertension were confined and hypertension non-pharmacological treatment, the following
empowered mainly on eating habits, exercises, and the stress limitations emerge from the research. Some limitations
of lifestyle without being complemented adequately by include the variations in the numbers of subjects in the
pharmacological interferences. However more recent studies, and the subjects’ backgrounds, intervention
research has affirmed that other than using the DASH diet to duration, and measuring instruments. All these have a
reduce high blood pressure, it does so in ways that have not bearing on the challenges regarding the generalization of the
been seen before. Prevention and control of hypertension; findings across the two kinds of research studies in a manner
sparking and aerobic movements, dynamic and static forms that is commensurate. Moreover, some papers are purely
of exercise such as endurance and strength. questionnaire-based, this makes the information received, to
a certain extent, reflect the subjective estimate or recalling
Long-term stress also suppresses the sympathetic of the participants.
nervous system, and some of the measures that can help
with stress include practicing mindfulness meditation or One more significant limitation of the current literature
doing yoga. From these observations, it therefore becomes is that many of the studies with non-pharmacologic
clear and understood that more emphasis is required for the interventions are conducted for a short period, which
incorporation of other non-pharmacological approaches in prevents the researchers from understanding the long-term
the handling of hypertension to improve the results. effectiveness of the interventions. Moreover, regarding the
analyzed sample of non-pharmacological interventions
VI. LIMITATIONS AND RECOMMENDATIONS ranging from dietary modification to exercise and stress
reduction approaches and complementary therapies, the
One of the primary limitations of this study was the study is beneficial because sometimes it remains unclear
reliance on self-reported data from respondents, which may which of the approaches may lead to exclusively positive
have introduced bias or inaccuracies in the reported usage of effects. Also, there are deficiencies in knowledge
non-pharmacological treatments and their perceived concerning some demographic variables, which might
effectiveness. Furthermore, the study's sample size of 100 predict the applicability and efficacy of these interventions.
individuals, although purposively selected, may not have
been sufficiently large or diverse to generalize the findings Therefore, there is needed culturally competent and
to the broader population of adults with hypertension. systems-oriented research. Such limitations will be
countered through increased reliance on standard procedures
The exclusion of pharmacological treatments limited and extended monitoring; the advancement of the
the scope of understanding the integrated management of understanding of non-pharmacological approaches to
hypertension, which often includes both pharmacological hypertension will be the outcome.
and non-pharmacological approaches. Another significant
limitation was the geographic focus of the study, which may VII. STRENGTH OF THE STUDY
have limited the generalizability of the findings to other
regions with different healthcare practices, cultural attitudes, This study explored the strengths of studying non-
and dietary habits. pharmacological approaches to hypertension. Holistic
management through strategies such as dietary changes,
Future research should have considered a more exercise, and stress reduction addressed multiple lifestyle
integrative approach that included both pharmacological and factors influencing hypertension, leading to comprehensive
non-pharmacological treatments to provide a holistic health improvements. By focusing on lifestyle modifications
understanding of hypertension management. This could rather than medications, patients experienced fewer adverse
have uncovered potential synergies and provided a more effects, avoiding complications like dizziness or fatigue.
comprehensive treatment guideline for patients. Lifestyle changes promoted lasting habits, helping maintain
Additionally, employing a longitudinal study design could healthy blood pressure levels over time and contributing to
have helped in assessing the long-term efficacy and long-term cardiovascular health.
compliance of non-pharmacological treatments. Expanding
the geographic scope and including diverse demographic Non-pharmacological interventions often involve low-
groups would have enhanced the generalizability of the cost or no-cost options, significantly reducing healthcare
findings. costs related to medications and their associated monitoring.
Engaging patients in their health management fostered a
[14]. Conn, B. M., Ejesi, K., & Foster, D. W. (2017). [28]. High blood pressure (hypertension) - Symptoms &
Acculturative stress as a moderator of the effect of causes - Mayo Clinic. (2022, September 15). Mayo
drinking motives on alcohol use and problems among Clinic. https://www.mayoclinic.org/diseases-
young adults. Addictive Behaviors, 75, 85–94. conditions/high-blood-pressure/symptoms-causes/syc-
https://doi.org/10.1016/j.addbeh.2017.06.017 20373410
[15]. Cristiano, C. (2018a, February 28). How to reduce [29]. Hypertension Pharmacological Treatment in Adults: A
your high blood pressure and take down hypertension. World Health Organization Guideline Executive
Healthline. https://www.healthline.com/health/high- Summary. Hypertension, 79(1), 293–301.
blood-pressure-hypertension/how-reduce-high-blood- https://doi.org/10.1161/hypertensionaha.121.18192
pressure#causes [30]. Kelly, T. M., Donovan, J. M., Cornelius, J. R.,
[16]. Desai AN. High Blood Pressure. JAMA. Bukstein, O. G., Delbridge, T. R., & Kinnane, J. M.
2020;324(12):1254–1255. (2005). Alcohol use disorder symptoms and risk-taking
doi:10.1001/jama.2020.11289.https://jamanetwork.co behavior as predictors of alcohol-related medical
m/journals/jama/fullarticle events among young adults treated in emergency
[17]. /2770851 departments. Addictive Behaviors.
[18]. Correlation. (n.d.). Introduction to Statistics | JMP. https://doi.org/10.1016/j.addbeh.2005.07.005
https://www.jmp.com/en_ph/statistics-knowledge- [31]. Kodela, P., Okeke, M., Guntuku, S., Lingamsetty, S. S.
portal/what-is- P., & Slonovschi, E. (2023).
correlation.html#:~:text=What%20is%20correlation% [32]. Management of Hypertension with Non-
3F,statement%20about pharmacological Interventions: A Narrative review.
[19]. %20cause%20and%20effect. [33]. Khan, T.M. et al. Non-pharmacological management
[20]. Desai, A. N. (2020). High blood pressure. JAMA, of hypertension: in the light of current research. Ir J
324(12), 1254. Med Sci 188, 437–452 (2019).
https://doi.org/10.1001/jama.2020.11289 https://doi.org/10.1007/s11845- 018-1889-8
[21]. Dhungana, R. R., Pedišić, Ž. & De Courten, M. [34]. Lowering blood pressure significantly reduced
(2022d). Implementation of nonpharmacological dementia risk in people with hypertension. (n.d.).
interventions for the treatment of hypertension in American Heart Association.
primary care: a narrative review of effectiveness, cost- https://newsroom.heart.org/news/lowering-blood-
effectiveness, barriers, and facilitators. BMC Primary pressure-significantly- reduced-dementia-risk-in-
Care, 23(1). https://doi.org/10.1186/s12875-022- people-with-hypertension
01884-8 [35]. Mahmood, S., Shah, K. U., Khan, T. M., Nawaz, S.,
[22]. Elkheshebi, A. (2021). The effects of Non- Rashid, H., Baqar, S. W. A., & Kamran, S. (2018c).
Pharmacological Intervention in the management of Non-pharmacological management of hypertension: in
essential blood pressure. the light of current research. Irish Journal of Medical
https://pubmed.ncbi.nlm.nih.gov/35228272/ Science, 188(2), 437–
[23]. Fu, J., Liu, Y., Zhang, L., Zhou, L., Li, D., Quan, H., [36]. 452. https://doi.org/10.1007/s11845-018- 1889-8
Zhu, L., Hu, F., Li, X., Meng, [37]. Malachias, M., Souza, W., Plavnik, F., Rodrigues, C. I.
[24]. S., Yan, R., Zhao, S., Onwuka, J. U., Yang, B., Sun, S., Brandão, A., Neves, M., Bortolotto, L., Franco, R.,
D., & Zhao, Y. (2020). Nonpharmacologic Figueiredo, C., Jardim, P., Amodeo, C., Barbosa, E.,
interventions for reducing blood pressure in adults with Koch, V. H., Gomes, M., Paula, R., Póvoa, R.,
prehypertension to established hypertension. Journal of Colombo, F., Filho, S. F., Miranda, R. D., . . . Júnior,
the American Heart Association. Cardiovascular and H. M. (2016b). Capítulo 6 - Tratamento não
Cerebrovascular Disease, 9(19). medicamentoso. Arquivos Brasileiros De Cardiologia,
https://doi.org/10.1161/jaha.120.016804 107(3)
[25]. Ghorani, H. A., Kulenthiran, S., Lauder, L., Böhm, M., [38]. Management of pain without medications. (2017,
& Mahfoud, F. (2021). September 12). Stanford Health Care.
[26]. Hypertension trials update. Journal of Human https://stanfordhealthcare.org/medical-
Hypertension, 35(5), 398–409. conditions/pain/pain/treatments/non-pharmacological-
https://doi.org/10.1038/s41371-020-00477-1 pain-management.html
[27]. Glynn, L. G., Murphy, A. W., Smith, S. M., Schroeder, [39]. Maniero, C., Lopuszko, A., Papalois, K. B., Gupta, A.,
K., & Fahey, T. (2010). Self- monitoring and other Kapil, V., & Khanji, M. Y. (2022d). Non-
non-pharmacological interventions to improve the pharmacological factors for hypertension management:
management of hypertension in primary care: a a systematic review of international guidelines.
systematic review. British Journal of General Practice, European Journal of Preventive Cardiology, 30(1), 17–
60(581), e476–e488. 33
https://doi.org/10.3399/bjgp10x544113
[40]. Mayo Clinic. 2022. 10 ways to control high blood [53]. Ried, K., Frank, O. R., Stocks, N. P., Fakler, P., &
pressure without medication.. Sullivan, T. (2008). Effect of garlic on blood pressure:
https://www.mayoclinic.org/diseases-conditions/high- A systematic review and meta-analysis. BMC
blood- pressure/in- depth/high-blood-pressure/art- Cardiovascular Disorders, 8(1).
20046974 https://doi.org/10.1186/1471-2261-8-13
[41]. McKay, D. L., Chen, C. O., Saltzman, E., & Blumberg, [54]. Shahzeydi, A., Joonbakhsh, F., Ajoodaniyan, N.,
J. B. (2010). Hibiscus Sabdariffa L. tea (Tisane) lowers Khaksar, S., Kalhor, F., Sabzghabaee, A. M., &
blood pressure in prehypertensive and mildly Kalhor, R. (2022). Comparing the pharmacology
hypertensive adults. ˜the œJournal of Nutrition/˜ the knowledge and performance of nurses and nursing
œJournal of Nutrition, 140(2), 298–303. students in the use of information resources in
https://doi.org/10.3945/jn.109.115097 pediatrics wards: An observational study. Sage Open
[42]. McLaney, E., Morassaei, S., Hughes, L., Davies, R., Medicine, 10, 205031212211353.
Campbell, M., & Di Prospero, L. (2022). A framework [55]. https://doi.org/10.1177/20503121221135397
for interprofessional team collaboration in a hospital
setting: Advancing team competencies and behaviours. [56]. Sternberg, A., Pandika, D., Elam, K. K., & Chassin, L.
Healthcare Management Forum, 35(2), 112– 117. (2018). The relation of parent alcohol disorder to
https://doi.org/10.1177/08404704211063584 young adult drinking outcomes mediated by parenting:
[43]. MedlinePlus. (2024). Blood Effects of developmentally limited versus persistent
pressure.https://medlineplus.gov/ency/article/007490.h parent alcohol disorder. Drug and Alcohol
tm, 188(2), 437–452. https://doi.org/10.1007/s11845- Dependence, 188, 224–231.
018- 1889-8 https://doi.org/10.1016/j.drugalcdep.2018.03.027
[44]. New study reaffirms risk of too much sodium, and too [57]. Stratton, S. (2016). Comprehensive reviews.
little potassium. (2023, January 24). www.heart.org. https://www.semanticscholar.org/paper/Comprehensiv
https://www.heart.org/en/news/2021/11/15/new-study- e-Reviews-
reaffirms-risk-of-too-much-sodium-too-little- Stratton/a56b4fd6756a1dee8c1932a5bc1af9214c22c5c
potassium 2
[45]. NCI Dictionary of Cancer Terms. (n.d.-d). Cancer.gov. [58]. Stratton, S. J. (2016). Comprehensive reviews.
https://www.cancer.gov/publications/dictionaries/cance Prehospital and Disaster Medicine, 31(4), 347–348.
r-terms/def/drug- therapy https://doi.org/10.1017/s1049023x16000649
[46]. NCI Dictionary of Cancer Terms. (n.d.-e). Cancer.gov. [59]. Taghavi, S. A., Wely, M., Jahanfar, S., &
https://www.cancer.gov/publications/dictionaries/cance Bazarganipour, F. (2021). Pharmacological and non‐
r-terms/def/kidney- failure pharmacological strategies for obese women with
[47]. Nguyen, H., Odelola, O. A., Rangaswami, J., & subfertility. The Cochrane Database of Systematic
Amanullah, A. (2013). A review of nutritional factors [60]. Timsina, Y. P., Pandey, P., Mondal, I. H., & Dar, A. H.
in hypertension management. International journal of (2023d). Non- pharmacological management of
hypertension, 2013, 698940. hypertension: A systematic review. Food Chemistry
https://doi.org/10.1155/2013/698940 Advance, 3, 100406.
[48]. Olvera Lopez E, Ballard BD, Jan A. Cardiovascular [61]. Verma, N., Rastogi, S., Chia, Y. C., Siddique, S.,
Disease. [Updated 2023 Aug 22]. Turana, Y., Cheng, H., Sogunuru, G. P., Tay, J. C.,
[49]. In: StatPearls [Internet]. Treasure Island (FL): Teo, B. W., Wang, T., Tsoi, K. K., & Kario, K. (2021).
StatPearls Publishing; 2024 Jan- [62]. Non‐ pharmacological management of hypertension.
https://www.ncbi.nlm.nih.gov/books/NBK535419/ Journal of Clinical Hypertension, 23(7), 1275–1283.
[50]. Primary aldosteronism. (2022, September 21). Johns [63]. Wang, C., Yuan, Y., Zheng, M., Pan, A., Wang, M.,
Hopkins Medicine. Zhao, M., Li, Y., Yao, S., Chen, S., Wu, S., & Xue, H.
https://www.hopkinsmedicine.org/health/conditions- (2020). Association of Age of Onset of Hypertension
and-diseases/primary- With Cardiovascular Diseases and Mortality. Journal
aldosteronism#:~:text=Primary%20aldosteronism%2C of the American College of Cardiology, 75(23), 2921–
%20also%20called%20 2930. https://doi.org/10.1016/j.jacc.2020.04.038
Conn's,potassium%20levels%20in%20your%20body [64]. What are complementary and integrative methods?
[51]. Professional, C. C. M. (n.d.-a). Blood pressure. (n.d.). American Cancer Society.
Cleveland Clinic. https://www.cancer.org/cancer/managing-
https://my.clevelandclinic.org/health/diagnostics/17649 cancer/treatment- types/complementary-and-
-blood-pressure integrative-medicine/complementary-and- alternative-
[52]. Professional, C. C. M. (n.d.-c). Vascular disease methods-and-cancer/what-are-complementary-and-
(Vasculopathy). Cleveland Clinic. integrative-
https://my.clevelandclinic.org/health/diseases/17604- methods.html#:~:text=Complementary%20methods%2
vascular-disease 0refers%20to%20supp
ortive,wellbeing%20and%20quality%20of%20life